Pharmacological approaches to methamphetamine dependence: a focused review

Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex

Goldstein, R. Z., & Volkow, N. D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1642 · Cited by 2,667 · see citing works

Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine

Thompson, P. M., Hayashi, K. M., Simon, S. L., Geaga, J. A., Hong, M., Sui, Y., Lee, J. Y., Toga, A. W., Ling, W. W., & London, E. D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0713-04.2004 · Cited by 760 · see citing works

Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis

Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9031-0 · Cited by 669 · see citing works

Drug addiction: the neurobiology of behaviour gone awry

Volkow, N. D., & Li, T. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1539 · Cited by 620 · see citing works

Involvement of the endocannabinoid system in drug addiction

Maldonado, R. J., Valverde, O., & Berrendero, F. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.008 · Cited by 584 · see citing works

Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain

Volkow, N. D., Fowler, J. S., Logan, J., Alexoff, D., Zhu, W., Telang, F., Wang, G., Jayne, M. C., Hooker, J. M., Wong, C., et al. (2009) · JAMA · doi:10.1001/jama.2009.351 · Cited by 529 · see citing works

Cognitive enhancing effects of modafinil in healthy volunteers

Turner, D. C., Robbins, T. W., Clark, L., Aron, A. R., Dowson, J. H., & Sahakian, B. J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1250-8 · Cited by 518 · see citing works

The need for speed: an update on methamphetamine addiction

Barr, A. M., Panenka, W. J., MacEwan, G. W., Thornton, A. E., Lang, D. J., Honer, W. G., & Lecomte, T. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0635 · Cited by 438 · see citing works

The prevalence of psychotic symptoms among methamphetamine users

McKetin, R., McLaren, J., Lubman, D. I., & Hides, L. M. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01496.x · Cited by 393 · see citing works

A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence

Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O'Brien, C. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300600 · Cited by 391 · see citing works

A multi‐site comparison of psychosocial approaches for the treatment of methamphetamine dependence

Rawson, R. A., Marinelli‐Casey, P., Anglin, M. D., Dickow, A., Frazier, Y., Gallagher, C., Galloway, G. P., Herrell, J., Huber, A., McCann, M. J., et al. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00707.x · Cited by 387 · see citing works

Mood Disturbances and Regional Cerebral Metabolic Abnormalities inRecently Abstinent Methamphetamine Abusers

London, E. D., Simon, S. L., Berman, S. M., Mandelkern, M. A., Lichtman, A. M., Bramen, J. E., Shinn, A. K., Miotto, K. A., Learn, J. E., Dong, Y., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.73 · Cited by 385 · see citing works

A Systematic Review of Modafinil

Ballon, J. S., & Feifel, D. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0406 · Cited by 351 · see citing works

Stimulant Medication Use, Misuse, and Abuse in an Undergraduate and Graduate Student Sample

White, B. P., Becker‐Blease, K. A., & Grace-Bishop, K. (2006) · Journal of American College Health · doi:10.3200/jach.54.5.261-268 · Cited by 333 · see citing works

The pharmacologic profile of mirtazapine.

de Boer, T. (1996) · PubMed · Cited by 330 · see citing works

Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder

Turner, D. C., Clark, L., Dowson, J., Robbins, T. W., & Sahakian, B. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.008 · Cited by 301 · see citing works

Brain DA D2 receptors predict reinforcing effects of stimulants in humans: Replication study

Volkow, N. D., Wang, G., Fowler, J. S., Thanos, P., Logan, J., Gatley, S. J., Gifford, A. J., Ding, Y., Wong, C., & Pappas, N. R. (2002) · Synapse · doi:10.1002/syn.10137 · Cited by 275 · see citing works

Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil

Bastoji, H., & Jouvet, M. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90014-0 · Cited by 270 · see citing works

Modafinil Improves Cognition and Attentional Set Shifting in Patients with Chronic Schizophrenia

Turner, D. C., Clark, L., Pomarol‐Clotet, E., McKenna, P. J., Robbins, T. W., & Sahakian, B. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300457 · Cited by 258 · see citing works

Dextroamphetamine for Cocaine-Dependence Treatment: A Double-Blind Randomized Clinical Trial

Grabowski, J., Rhoades, H., Schmitz, J., Stotts, A., Daruzska, L. A., Creson, D., & Moeller, F. G. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00010 · Cited by 243 · see citing works

GABAB receptor agonists for the treatment of drug addiction: a review of recent findings

Cousins, M. S., Roberts, D. C. S., & de Wit, H. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00163-6 · Cited by 240 · see citing works

Modafinil for the treatment of cocaine dependence

Anderson, A. L., Reid, M. S., Li, S.-H., Holmes, T., Shemanski, L., Slee, A., Smith, E. V., Kahn, R., Chiang, N., Vocci, F., et al. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.04.015 · Cited by 235 · see citing works

Bupropion for the treatment of methamphetamine dependence

Elkashef, A. M., Rawson, R. A., Anderson, A. L., Li, S.-H., Holmes, T., Smith, E. V., Chiang, N., Kahn, R., Vocci, F., Ling, W., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301481 · Cited by 234 · see citing works

Treatment of cocaine dependent treatment seekers with adult ADHD: Double-blind comparison of methylphenidate and placebo

Levin, F. R., Evans, S. M., Brooks, D. J., & Garawi, F. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.07.004 · Cited by 220 · see citing works

A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse

Dwoskin, L. P., & Crooks, P. A. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00899-1 · Cited by 219 · see citing works

Vaccine Pharmacotherapy for the Treatment of Cocaine Dependence

Martell, B. A., Mitchell, E. S., Poling, J. C., Gonsai, K., & Kosten, T. R. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.032 · Cited by 208 · see citing works

Enlarged striatum in abstinent methamphetamine abusers: A possible compensatory response

Chang, L., Cloak, C. C., Patterson, K., Grob, C. S., Miller, E. N., & Ernst, T. M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.039 · Cited by 206 · see citing works

Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users

McCann, U. D., Kuwabara, H., Kumar, A., Palermo, M., Abbey, R., Brašić, J. R., Ye, W., Alexander, M., Dannals, R. F., Wong, D. F., et al. (2007) · Synapse · doi:10.1002/syn.20471 · Cited by 205 · see citing works

Executive control deficits in substance-dependent individuals: A comparison of alcohol, cocaine, and methamphetamine and of men and women

van der Plas, E. A. A., Crone, E. A., van den Wildenberg, W. P. M., Tranel, D., & Bechara, A. (2008) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390802484797 · Cited by 201 · see citing works

A double-blind, placebo-controlled trial of modafinil for cocaine dependence

Dackis, C. A., Kampman, K. M., Lynch, K. G., Plebani, J. G., Pettinati, H. M., Sparkman, T., & O'Brien, C. P. (2012) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.12.014 · Cited by 187 · see citing works

Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study

Dackis, C. A., Lynch, K. G., Yu, E., Samaha, F. F., Kampman, K. M., Cornish, J., Rowan, A. B., Poole, S. A., White, L., & O’Brien, C. P. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00335-6 · Cited by 186 · see citing works

Naltrexone for the Treatment of Amphetamine Dependence: A Randomized, Placebo-Controlled Trial

Jayaram-Lindström, N., Hammarberg, A., Beck, O., & Franck, J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08020304 · Cited by 185 · see citing works

A Comparison of Aripiprazole, Methylphenidate, and Placebo for Amphetamine Dependence

Tiihonen, J., Kuoppasalmi, K. I., Föhr, J., Tuomola, P., Kuikanmäki, O., Vorma, H., Sokero, P., Haukka, J. K., & Meririnne, E. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.1.160 · Cited by 178 · see citing works

Effects of modafinil on working memory processes in humans

M�ller, U., Steffenhagen, N., Regenthal, R., & Bublak, P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1926-3 · Cited by 170 · see citing works

Bupropion Reduces Methamphetamine-Induced Subjective Effects and Cue-Induced Craving

Newton, T. F., Roache, J. D., Garza, R. D. L., FONG, T. W., Wallace, C. L., Li, S.-H., Elkashef, A. M., Chiang, N., & Kahn, R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300979 · Cited by 163 · see citing works

Modafinil: A Double-Blind Multicentric Study

Billiard, M. M., Besset, A., Montplaisir, J. Y., Laffont, F., Goldenberg, F., Weill, J. S., & Lubin, S. (1994) · SLEEP · doi:10.1093/sleep/17.suppl_8.s107 · Cited by 161 · see citing works

Mechanisms of modafinil: A review of current research

Gerrard, P., & Malcolm, R. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a911 · Cited by 160 · see citing works

A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence

Shearer, J., Darke, S., Rodgers, C., Slade, T., Van Beek, I., Lewis, J., Brady, D., McKetin, R., Mattick, R. P., & Wodak, A. (2009) · Addiction · doi:10.1111/j.1360-0443.2008.02437.x · Cited by 159 · see citing works

Stimulant Psychosis: Symptom Profile and Acute Clinical Course

Harris, D. S., & Batki, S. L. (2000) · American Journal on Addictions · doi:10.1080/10550490050172209 · Cited by 153 · see citing works

Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence

SHOPTAW, S. J., Heinzerling, K. G., Rotheram-Fuller, E. J., Steward, T., Wang, J., Swanson, A., Garza, R. D. L., Newton, T., & Ling, W. W. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.03.010 · Cited by 150 · see citing works

Psychiatric and Substance Dependence Comorbidities, Sexually Transmitted Diseases, and Risk Behaviors Among Methamphetamine-Dependent Gay and Bisexual Men Seeking Outpatient Drug Abuse Treatment

SHOPTAW, S. J., Peck, J. A., Reback, C. J., & Rotheram-Fuller, E. J. (2003) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2003.10400511 · Cited by 147 · see citing works

Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence

SHOPTAW, S. J., Huber, A., Peck, J. A., Yang, X., Liu, J., Dang, J., Roll, J. M., Shapiro, B., Rotheram-Fuller, E. J., & Ling, W. W. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.03.005 · Cited by 146 · see citing works

Modafinil: Preclinical, Clinical, and Post-Marketing Surveillance—A Review of Abuse Liability Issues

Myrick, H., Malcolm, R. J., Taylor, B. R., & LaRowe, S. D. (2004) · Annals of Clinical Psychiatry · doi:10.1080/10401230490453743 · Cited by 137 · see citing works

Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function

Fleckenstein, A. E., Haughey, H. M., Metzger, R. R., Kokoshka, J. M., Riddle, E. L., Hanson, J. E., Gibb, J. W., & Hanson, G. R. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00588-9 · Cited by 134 · see citing works

A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence

Johnson, B. A., Ait‐Daoud, N., Elkashef, A. M., Smith, E. V., Kahn, R., Vocci, F., Li, S.-H., Bloch, D. A., & the Methamphetamine Study Group (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007778 · Cited by 131 · see citing works

Aripiprazole for schizophrenia

El-Sayeh, H., Morganti, C., & Adams, C. E. (2006) · The British Journal of Psychiatry · doi:10.1192/bjp.189.2.102 · Cited by 129 · see citing works

High affinity dopamine reuptake inhibitors as potential cocaine antagonists: A strategy for drug development

Rothman, R. B. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90466-5 · Cited by 126 · see citing works

Endocannabinoid System Modulates Relapse to Methamphetamine Seeking: Possible Mediation by the Arachidonic Acid Cascade

Anggadiredja, K., Nakamichi, M., Hiranita, T., Tanaka, H., Shoyama, Y., Watanabe, S., & Yamamoto, T. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300454 · Cited by 125 · see citing works

A review of rivastigmine: A reversible cholinesterase inhibitor

Williams, B. R., Nazarians, A., & Gill, M. A. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80160-1 · Cited by 122 · see citing works

Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence

Longo, M., Wickes, W., Smout, M., Harrison, S., Cahill, S., & White, J. M. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02717.x · Cited by 122 · see citing works

Pharmacotherapy of Methamphetamine Addiction: An Update

Elkashef, A. M., Vocci, F. J., Hanson, G. R., White, J. M., WICKES, W. A., & Tiihonen, J. (2008) · Substance Abuse · doi:10.1080/08897070802218554 · Cited by 121 · see citing works

Safety and efficacy of ?-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction

Brodie, J. D., Figueroa, E., LASKA, E. M., & Dewey, S. L. (2004) · Synapse · doi:10.1002/syn.20097 · Cited by 121 · see citing works

Prospective memory impairment in former users of methamphetamine

Rendell, P. G., Mazur, M., & Henry, J. D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1408-0 · Cited by 120 · see citing works

Emerging research on methamphetamine

Maxwell, J. C. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165592.52811.84 · Cited by 117 · see citing works

Approaches to the development of medications for the treatment of methamphetamine dependence

Vocci, F. J., & Appel, N. M. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01772.x · Cited by 114 · see citing works

Naltrexone Attenuates the Subjective Effects of Amphetamine in Patients with Amphetamine Dependence

Jayaram‐Lindström, N., Konstenius, M., Eksborg, S., Beck, O., Hammarberg, A., & Franck, J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301572 · Cited by 107 · see citing works

Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine

Frey, K. A., Kilbourn, M. R., & Robinson, T. E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01152-7 · Cited by 104 · see citing works

Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence

Heinzerling, K. G., SHOPTAW, S. J., Peck, J. A., Yang, X., Liu, J., Roll, J. M., & Ling, W. W. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.03.019 · Cited by 102 · see citing works

Corticolimbic dysregulation and chronic methamphetamine abuse

Baicy, K., & London, E. D. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01777.x · Cited by 101 · see citing works

Does Modafinil Enhance Cognitive Performance in Young Volunteers Who Are Not Sleep-Deprived?

Randall, D. C., Viswanath, A., Bharania, P., Elsabagh, S., Hartley, D. E., Shneerson, J. M., & File, S. E. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000155816.21467.25 · Cited by 97 · see citing works

Methylphenidate and cocaine: the same effects on gene regulation?

YANO, M., & STEINER, H. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.004 · Cited by 94 · see citing works

Effects of intrastriatal cannabinoids on rotational behavior in rats: Interactions with the dopaminergic system

Sa√±udo-Pe√±a, M. C., Force, M., Tsou, K., Miller, A. S., & Walker, J. M. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199810)30:2 · Cited by 93 · see citing works

Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence

Shearer, J., WODAK, A. D., Mattick, R. P., van Beek, I., Lewis, J. E., Hall, W., & Dolan, K. A. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.96912898.x · Cited by 93 · see citing works

Clinically Significant Drug Interactions with Cholinesterase Inhibitors

Bentu??-Ferrer, D., Tribut, O., Polard, É., & Allain, H. (2003) · CNS Drugs · doi:10.2165/00023210-200317130-00002 · Cited by 92 · see citing works

Suppression of methamphetamine-seeking behavior by nicotinic agonists

Hiranita, T., Nawata, Y., Sakimura, K., Anggadiredja, K., & Yamamoto, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600347103 · Cited by 91 · see citing works

Location, location: using functional magnetic resonance imaging to pinpoint brain differences relevant to stimulant use

Aron, J. L., & Paulus, M. P. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01778.x · Cited by 91 · see citing works

Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels

Vergo, S. B., Johansen, J. L., Leist, M., & Lotharius, J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.028 · Cited by 89 · see citing works

Effects of Naltrexone on the Subjective Response to Amphetamine in Healthy Volunteers

Jayaram‐Lindström, N., Wennberg, P., Hurd, Y. L., & Franck, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000144893.29987.e5 · Cited by 88 · see citing works

Electrocardiographic abnormalities in methamphetamine abusers

Haning, W., & Goebert, D. A. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01776.x · Cited by 86 · see citing works

Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users

Lapworth, K., Dawe, S., Davis, P. J., Kavanagh, D. J., Young, R. M., & Saunders, J. B. (2008) · Addictive Behaviors · doi:10.1016/j.addbeh.2008.11.014 · Cited by 86 · see citing works

Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual

McGregor, C., Srisurapanont, M., Mitchell, A., Wickes, W., & White, J. M. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.12.003 · Cited by 82 · see citing works

The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine‐induced dopaminergic deficits

Volz, T. J., Hanson, G. R., & Fleckenstein, A. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04419.x · Cited by 76 · see citing works

Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats

Munzar, P., Baumann, M. H., Shoaib, M. C., & Goldberg, S. R. (1999) · Psychopharmacology · doi:10.1007/s002130050836 · Cited by 76 · see citing works

Aripiprazole Attenuates the Discriminative-Stimulus and Subject-Rated Effects of D-Amphetamine in Humans

Lile, J. A., Stoops, W. W., Vansickel, A. R., Glaser, P. E. A., Hays, L. R., & Rush, C. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300803 · Cited by 76 · see citing works

Nonmedical Use of Prescription Stimulants Among Students

Arria, A. M., & Wish, E. D. (2006) · Pediatric Annals · doi:10.3928/0090-4481-20060801-09 · Cited by 76 · see citing works

A placebo‐controlled trial of mirtazapine for the management of methamphetamine withdrawal

CRUICKSHANK, C. C., MONTEBELLO, M. E., DYER, K. R., QUIGLEY, A., BLASZCZYK, J., TOMKINS, S., & SHAND, D. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801935672 · Cited by 74 · see citing works

Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta‐analysis of randomized controlled clinical trials

Cervelló, X. C., Casas, M., Vidal, X., Bosch, R., Roncero, C., Ramos‐Quiroga, J. A., & Capellà, D. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01943.x · Cited by 74 · see citing works

Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in rats

Byrnes-Blake, K. A., Laurenzana, E. M., Carroll, F. I., Abraham, P., Gentry, W. B., Landes, R. D., & Owens, S. M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01313-x · Cited by 73 · see citing works

Modulation of Dopamine Transmission by 5HT2C and 5HT3 Receptors: A Role in the Antidepressant Response

Dremencov, E., Weizman, Y., Kinor, N., Gispan-Herman, I., & Yadid, G. (2006) · Current Drug Targets · doi:10.2174/138945006775515491 · Cited by 73 · see citing works

Lobeline Analogs with Enhanced Affinity and Selectivity for Plasmalemma and Vesicular Monoamine Transporters

Miller, D. K., Crooks, P. A., Zheng, G., Grinevich, V. P., Norrholm, S. D., & Dwoskin, L. P. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068098 · Cited by 73 · see citing works

Bupropion increases striatal vesicular monoamine transport

Rau, K. S., Birdsall, E., Hanson, J. E., Johnson‐Davis, K. L., Carroll, F. I., Wilkins, D. G., Gibb, J. W., Hanson, G. R., & Fleckenstein, A. E. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.05.004 · Cited by 72 · see citing works

Effects of Murine-Derived Anti-Methamphetamine Monoclonal Antibodies on (+)-Methamphetamine Self-Administration in the Rat

McMillan, D. E., Hardwick, W. C., Li, M., Gunnell, M. G., Carroll, F. I., Abraham, P., & Owens, S. M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061762 · Cited by 71 · see citing works

Vaccination against nicotine: an emerging therapy for tobacco dependence

Maurer, P., & Bachmann, M. F. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.11.1775 · Cited by 70 · see citing works

Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats

Byrnes-Blake, K. A., Carroll, F. I., Abraham, P., & Owens, S. M. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(00)00019-9 · Cited by 69 · see citing works

Lobelane decreases methamphetamine self-administration in rats

Neugebauer‎, N. M., Harrod, S. B., Stairs, D. J., Crooks, P. A., Dwoskin, L. P., & Bardo, M. T. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.003 · Cited by 67 · see citing works

Naltrexone attenuates cue- but not drug-induced methamphetamine seeking: a possible mechanism for the dissociation of primary and secondary reward

Anggadiredja, K., Sakimura, K., Hiranita, T., & Yamamoto, T. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.051 · Cited by 65 · see citing works

Methamphetamine dependence and human immunodeficiency virus risk behavior

Rawson, R. A., Gonzales, R. E., Antonini, V. P., Ang, A., Marinelli‐Casey, P., & Brummer, J. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.11.003 · Cited by 64 · see citing works

Safety of intravenous methamphetamine administration during treatment with bupropion

Newton, T. F., Roache, J. D., Garza, R. D. L., Fong, T., Wallace, C. L., Li, S.-H., Elkashef, A. M., Chiang, N., & Kahn, R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0102-8 · Cited by 63 · see citing works

Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers

Newton, T. F., Reid, M. S., Garza, R. D. L., Mahoney, J. J., Abad, A., Condos, R., Palamar, J. J., Halkitis, P. N., Mojisak, J., Anderson, A., et al. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009097 · Cited by 61 · see citing works

Provigil (Modafinil) Plus Cognitive Behavioral Therapy for Methamphetamine Use in HIV+ Gay Men: A Pilot Study

McElhiney, M. C., Rabkin, J. G., Rabkin, R., & Nunes, E. V. (2009) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990802342907 · Cited by 61 · see citing works

Management of methamphetamine abuse and dependence

Ling, W. W., Rawson, R. A., & SHOPTAW, S. J. (2006) · Current Psychiatry Reports · doi:10.1007/s11920-006-0035-x · Cited by 60 · see citing works

Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone

Chiu, C., Ma, T., & Ho, I. K. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.05.028 · Cited by 60 · see citing works

Methamphetamine Dependence: A Closer Look at Treatment Response and Clinical Characteristics Associated with Route of Administration in Outpatient Treatment

Rawson, R. A., Gonzales, R. E., Marinelli‐Casey, P., & Ang, A. (2007) · American Journal on Addictions · doi:10.1080/10550490701389864 · Cited by 58 · see citing works

The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers

Garza, R. D. L., Mahoney, J. J., Culbertson, C., SHOPTAW, S. J., & Newton, T. F. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.12.010 · Cited by 58 · see citing works

A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine

Stoops, W. W., Lile, J. A., Glaser, P. E. A., & Rush, C. R. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.02.004 · Cited by 57 · see citing works

MEMORY IMPAIRMENT IN METHAMPHETAMINE DEPENDENT PATIENTS

MOON, M., Soo, K., Park, J.-W., & Kim, D. (2007) · International Journal of Neuroscience · doi:10.1080/00207450500535503 · Cited by 57 · see citing works

Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats

Gentry, W. B., Laurenzana, E. M., Williams, D. K., West, J. R., Berg, R. J., Terlea, T., & Owens, S. M. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.01.008 · Cited by 54 · see citing works

Development of active and passive human vaccines to treat methamphetamine addiction

Gentry, W. B., Rüedi‐Bettschen, D., & Owens, S. M. (2009) · Human Vaccines · doi:10.4161/hv.5.4.7456 · Cited by 54 · see citing works

Effects of acute topiramate dosing on methamphetamine-induced subjective mood

Johnson, B. A., Roache, J. D., Ait‐Daoud, N., Wells, L. T., Wallace, C. L., Dawes, M. A., Liu, L., & Wang, X. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006401 · Cited by 52 · see citing works

Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats

Byrnes-Blake, K. A., Laurenzana, E. M., Landes, R. D., Gentry, W. B., & Owens, S. M. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.08.016 · Cited by 49 · see citing works

Drug-Induced Psychosis Associated with Crystalline Methamphetamine

Dore, G., & Sweeting, M. (2006) · Australasian Psychiatry · doi:10.1080/j.1440-1665.2006.02252.x · Cited by 47 · see citing works

Short-term Treatment of Cocaine and/or Methamphetamine Abuse With Vigabatrin

Fechtner, R. D. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.9.1257 · Cited by 46 · see citing works

Neuropsychotoxicity of Abused Drugs: Molecular and Neural Mechanisms of Neuropsychotoxicity Induced by Methamphetamine, 3,4-Methylenedioxymethamphetamine (Ecstasy), and 5-Methoxy-N,N-diisopropyltryptamine (Foxy)

Nakagawa, T., & Kaneko, S. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fm0070141 · Cited by 43 · see citing works

Development of Immunopharmacotherapy Against Drugs of Abuse

Meijler, M. M., Matsushita, M., Wirsching, P., & Janda, K. D. (2004) · Current Drug Discovery Technologies · doi:10.2174/1570163043484851 · Cited by 41 · see citing works

Alcohol & Drug Abuse: Long-Acting Stimulants for the Treatment of Attention-Deficit Disorder in Cocaine-Dependent Adults

Castañeda, R., Levy, R., Hardy, M., & Trujillo, M. (2000) · Psychiatric Services · doi:10.1176/appi.ps.51.2.169 · Cited by 40 · see citing works

Fluoxetine as a Potential Pharmacotherapy for Methamphetamine Dependence

Takamatsu, Y., Yamamoto, H., Ogai, Y., Hagino, Y., Markou, A., & Ikeda, K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.026 · Cited by 39 · see citing works

Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals

Johnson, B. A., Roache, J. D., Ait‐Daoud, N., Wells, L. T., Wallace, C. L., Dawes, M. A., Liu, L., & Wang, X. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.08.002 · Cited by 38 · see citing works

Aripiprazole as a potential pharmacotherapy for stimulant dependence: Human laboratory studies with d-amphetamine.

Stoops, W. W. (2006) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.14.4.413 · Cited by 38 · see citing works

Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers

Garza, R. D. L., SHOPTAW, S. J., & Newton, T. F. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008456 · Cited by 38 · see citing works

Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d -methamphetamine's positive subjective effects: a preliminary study

Johnson, B. A., Roache, J. D., Bordnick, P. S., & Ait‐Daoud, N. (1999) · Psychopharmacology · doi:10.1007/s002130051007 · Cited by 37 · see citing works

Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase‐3 in caudate‐putamen

Pereira, F. C., Lourenço, E. S., Borges, F., Morgadinho, T., Ribeiro, C., Macedo, T. R. A., & Ali, S. F. (2006) · Synapse · doi:10.1002/syn.20285 · Cited by 37 · see citing works

An Open-Label Pilot Study of Risperidone in the Treatment of Methamphetamine Dependence

Meredith, C. W., Jaffe, C., Yanasak, E., Cherrier, M., & Saxon, A. J. (2007) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2007.10399875 · Cited by 37 · see citing works

An Exploratory Study: The Use of Paroxetine for Methamphetamine Craving

Piasecki, M. P., Steinagel, G. M., Thienhaus, O. J., & Kohlenberg, B. S. (2002) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2002.10399967 · Cited by 35 · see citing works

Involvement of cannabinoid CB1 and CB2 receptor activity in the development of behavioural sensitization to methamphetamine effects in mice.

Landa, L., Šulcová, A., & Šlais, K. (2007) · PubMed · Cited by 35 · see citing works

Lobeline effects on tonic and methamphetamine-induced dopamine release

Wilhelm, C., Johnson, R. A., Eshleman, A. J., & Janowsky, A. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.11.019 · Cited by 34 · see citing works

An open clinical trial of naltrexone for amphetamine dependence: Compliance and tolerability

Jayaram‐Lindström, N., Wennberg, P., Beck, O., & Franck, J. (2005) · Nordic Journal of Psychiatry · doi:10.1080/08039480510023052 · Cited by 33 · see citing works

Modafinil in Diurnal Sleepiness. A Study of 123 Patients

Laffont, F., Mayer, G. J., & Minz, M. (1994) · SLEEP · doi:10.1093/sleep/17.suppl_8.s113 · Cited by 33 · see citing works

Tobacco addiction and pharmacological interventions

Garrett, B. E., Rose, C. A., & Henningfield, J. E. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.10.1545 · Cited by 32 · see citing works

Treatment for amphetamine withdrawal

Srisurapanont, M., Jarusuraisin, N., & Kittirattanapaiboon, P. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003021 · Cited by 27 · see citing works

Effects of Methamphetamine and Lobeline on Vesicular Monoamine and Dopamine Transporter-Mediated Dopamine Release in a Cotransfected Model System

Wilhelm, C., Johnson, R. A., Lysko, P. G., Eshleman, A. J., & Janowsky, A. J. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067314 · Cited by 27 · see citing works

The future of vaccines in the management of addictive disorders

Orson, F. M., Kinsey, B. M., Singh, R. A. K., Wu, Y. L., Gardner, T. J., & Kosten, T. R. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0049-z · Cited by 24 · see citing works

Methamphetamine Quantitative Urine Concentrations during a Controlled Trial of Fluoxetine Treatment: Preliminary Analysis

Batki, S. L., MOON, J., Delucchi, K., Bradley, M. S., HERSH, D., Smolar, S., Mengis, M. M., LEFKOWITZ, E., SEXE, D., MORELLO, L., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06688.x · Cited by 21 · see citing works

The role of substitute therapy in the treatment of problem amphetamine use

Klee, H., Wright, S., Carnwath, T., & MERRILL, J. (2001) · Drug and Alcohol Review · doi:10.1080/09595230120092715 · Cited by 21 · see citing works

Open-Label Study of a Proprietary Treatment Program Targeting Type A γ-Aminobutyric Acid Receptor Dysregulation in Methamphetamine Dependence

Urschel, H. C., Hanselka, L. L., Gromov, I., White, L., & Baron, M. I. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.10.1170 · Cited by 20 · see citing works

The cardiovascular and subjective effects of methamphetamine combined with γ-vinyl-γ-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers

Garza, R. D. L., Zorick, T. S., Heinzerling, K. G., Nusinowitz, S., London, E. D., SHOPTAW, S. J., Moody, D. E., & Newton, T. F. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.08.007 · Cited by 20 · see citing works

Effects of anti-phencyclidine and anti-(+)-methamphetamine monoclonal antibodies alone and in combination on the discrimination of phencyclidine and (+)-methamphetamine by pigeons

Daniels, J., Wessinger, W. D., Hardwick, W. C., Li, M., Gunnell, M. G., Hall, C., Owens, S. M., & McMillan, D. E. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0299-6 · Cited by 18 · see citing works

Involvement of 5‐HT3receptors in the development and expression of methamphetamine‐induced behavioral sensitization: 5‐HT3Areceptor channel and binding study

Yoo, J., Cho, J.-H., Yu, H., Lee, K., Lee, B., Jeong, S. M., Nah, S.-Y., Kim, H., Lee, S., & Jang, C. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04137.x · Cited by 17 · see citing works

Biotechnology and the Treatment of Addictive Disorders

Elkashef, A. M., Biswas, J., Acri, J. B., & Vocci, F. J. (2007) · BioDrugs · doi:10.2165/00063030-200721040-00006 · Cited by 16 · see citing works

The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.

Gibb, J. W., Dm, S., Dc, S., & Gr, H. (1987) · PubMed · Cited by 13 · see citing works

Development of murine monoclonal antibodies to methamphetamine and methamphetamine analogues

Danger, Y., Gadjou, C., Devys, A., Galons, H., Blanchard, D., & Folléa, G. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.10.017 · Cited by 11 · see citing works

Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals

Johnson, B. A., Wells, L. T., Roache, J. D., Wallace, C. L., Ait‐Daoud, N., Dawes, M. A., Liu, L., Wang, X., & Javors, M. A. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.11.011 · Cited by 9 · see citing works

Effects of Tetrabenazine on Methamphetamine-Induced Hyperactivity in Mice are Dependent on Order and Time-Course of Administration

Kuribara, H. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00123-2 · Cited by 7 · see citing works

Drug-induced psychosis associated with crystalline methamphetamine

Dore, G., & Sweeting, M. (2006) · Australasian Psychiatry · doi:10.1111/j.1440-1665.2006.02252.x · Cited by 7 · see citing works

Is Hepatitis C Infection Associated with Increased Risk of Depression in Persons with Methamphetamine Dependence?

Vigil, O., Woods, S. P., Moran, L. M., Letendre, S. L., Casey, C. Y., Grant, I., & Atkinson, J. H. (2007) · American Journal on Addictions · doi:10.1080/10550490701525731 · Cited by 3 · see citing works

[Modafinil (Midiodal): wakefulness stimulant in narcoleptic patients].

Arnulf, I., & Derenne, J. (2000) · PubMed · Cited by 2 · see citing works

Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature

Courtney, K. E., & Ray, L. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.003 · Cited by 502 · see citing works

Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings

Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299 · see citing works

Gamma-aminobutyric acid and probiotics: Multiple health benefits and their future in the global functional food and nutraceuticals market

Diez-Gutiérrez, L., Vicente, L. S., Barrón, L. J. R., Villarán, M. C., & Chávarri, M. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103669 · Cited by 257 · see citing works

Synthetic cathinones: Chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as “bath salts” or “plant food”

Coppola, M., & Mondola, R. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.03.009 · Cited by 239 · see citing works

Mirtazapine to Reduce Methamphetamine Use: A Randomized Controlled Trial

Colfax, G. N. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.124 · Cited by 175 · see citing works

The clinical toxicology of metamfetamine

Schep, L. J., Slaughter, R. J., & Beasley, D. M. G. (2010) · Clinical Toxicology · doi:10.3109/15563650.2010.516752 · Cited by 165 · see citing works

The new drug phenomenon

Brandt, S. D., King, L. A., & Evans-Brown, M. J. (2014) · Drug Testing and Analysis · doi:10.1002/dta.1686 · Cited by 164 · see citing works

Pharmacotherapy for methamphetamine/amphetamine use disorder—a systematic review and meta‐analysis

Chan, B., Freeman, M., Kondo, K., Ayers, C., Montgomery, J., Paynter, R., & Kansagara, D. (2019) · Addiction · doi:10.1111/add.14755 · Cited by 160 · see citing works

Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial

Coffin, P. O., Santos, G.-M., Hern, J., Vittinghoff, E., Walker, J. E., Matheson, T., Santos, D., Colfax, G., & Batki, S. L. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3655 · Cited by 139 · see citing works

Barriers to accessing methamphetamine treatment: A systematic review and meta-analysis

Cumming, C., Troeung, L., Young, J. T., Kelty, E. A., & Preen, D. B. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.10.001 · Cited by 132 · see citing works

Effect of Modafinil on Learning and Task-Related Brain Activity in Methamphetamine-Dependent and Healthy Individuals

Ghahremani, D. G., Tabibnia, G., Monterosso, J. R., Hellemann, G., Poldrack, R. A., & London, E. D. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.233 · Cited by 119 · see citing works

The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), methamphetamine and d-amphetamine

Steinkellner, T., Freissmuth, M., Sitte, H. H., & Montgomery, T. (2011) · Biological Chemistry · doi:10.1515/bc.2011.016 · Cited by 106 · see citing works

Glial cell modulators attenuate methamphetamine self-administration in therat

Snider, S. E., Hendrick, E. S., & Beardsley, P. M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.016 · Cited by 109 · see citing works

Efficacy of psychostimulant drugs for amphetamine abuse or dependence

Pérez‐Mañá, C., Cervelló, X. C., Torrens, M., Capellà, D., & Farré, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009695.pub2 · Cited by 93 · see citing works

Low frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex transiently increases cue-induced craving for methamphetamine: A preliminary study

Li, X.-B., Malcolm, R., Huebner, K., Hanlon, C., Taylor, J. J., Brady, K., George, M., & See, R. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.08.012 · Cited by 86 · see citing works

Pharmacotherapy for amphetamine dependence: A systematic review

Lee, N., Jenner, L., Harney, A., & Cameron, J. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.06.038 · Cited by 85 · see citing works

The neurobiological mechanisms of physical exercise in methamphetamine addiction

Morais, A., Pita, I. R., Ribeiro, C., & Pereira, F. C. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12788 · Cited by 78 · see citing works

Impact of Distinct Chemical Structures for the Development of a Methamphetamine Vaccine

Moreno, A. Y., Mayorov, A. V., & Janda, K. D. (2011) · Journal of the American Chemical Society · doi:10.1021/ja108807j · Cited by 80 · see citing works

The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction

Sambo, D. O., Lebowitz, J. J., & Khoshbouei, H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.009 · Cited by 75 · see citing works

Strategy To Fabricate Naked-Eye Readout Ultrasensitive Plasmonic Nanosensor Based on Enzyme Mimetic Gold Nanoclusters

Zhao, Q., Huang, H., Zhang, L., Wang, L., Zeng, Y., Xia, X., Liu, F., & Chen, Y. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04089 · Cited by 73 · see citing works

Dopaminergic neuronal injury in the adult rat brain following neonatal exposure to lipopolysaccharide and the silent neurotoxicity

Fan, L., Tien, L., Zheng, B., Pang, Y., Lin, R. C. S., Simpson, K. L., Ma, T., Rhodes, P. G., & Cai, Z. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.09.020 · Cited by 71 · see citing works

Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial

Anderson, A. L., Li, S.-H., Markova, D., Holmes, T. H., Chiang, N., Kahn, R., Campbell, J., Dickerson, D. L., Galloway, G. P., Haning, W., et al. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.036 · Cited by 70 · see citing works

Current and Emerging Treatments for Methamphetamine Use Disorder

Moszczyńska, A. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210803091637 · Cited by 67 · see citing works

Aripiprazole for the treatment of methamphetamine dependence: a randomized, double‐blind, placebo‐controlled trial

Coffin, P. O., Santos, G., Das, M., Santos, D., Huffaker, S., Matheson, T., Gasper, J. J., Vittinghoff, E., & Colfax, G. N. (2012) · Addiction · doi:10.1111/add.12073 · Cited by 67 · see citing works

Epigenetics: a link between addiction and social environment

Ajonijebu, D. C., Abboussi, O., Russell, V. A., Mabandla, M. V., & Daniels, W. M. U. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2493-1 · Cited by 65 · see citing works

Effects of the Trace Amine Associated Receptor 1 Agonist RO5263397 on Abuse-Related Behavioral Indices of Methamphetamine in Rats

Jing, L., Zhang, Y., & Li, J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu060 · Cited by 58 · see citing works

Regional c-Fos and FosB/ΔFosB expression associated with chronic methamphetamine self-administration and methamphetamine-seeking behavior in rats

Cornish, J. L., Hunt, G. E., Robins, L., & McGregor, I. S. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.004 · Cited by 57 · see citing works

Randomized controlled trial of a positive affect intervention for methamphetamine users

Carrico, A. W., Gόmez, W., Jain, J., Shoptaw, S., Discepola, M. V., Olem, D., Lagana-Jackson, J., Andrews, R., Neilands, T. B., Dilworth, S. E., et al. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.029 · Cited by 56 · see citing works

Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis

Bhatt, M., Zielinski, L., Baker-Beal, L., Bhatnagar, N., Mouravska, N., Laplante, P., Worster, A., Thabane, L., & Samaan, Z. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0370-x · Cited by 56 · see citing works

Recent advances in developing optical and electrochemical sensors for analysis of methamphetamine: A review

Khorablou, Z., Shahdost-fard, F., Razmi, H., Yola, M. L., & Karimi‐Maleh, H. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.130393 · Cited by 56 · see citing works

The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice

Fujita, Y., Kunitachi, S., Iyo, M., & Hashimoto, K. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.01.005 · Cited by 56 · see citing works

Psychological treatment for methamphetamine use and associated psychiatric symptom outcomes: A systematic review

Stuart, A. M., Baker, A. L., Denham, A. M. J., Lee, N. K., Hall, A., Oldmeadow, C., Dunlop, A., Bowman, J., & McCarter, K. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.09.005 · Cited by 49 · see citing works

A virtual reality counterconditioning procedure to reduce methamphetamine cue-induced craving

Wang, Y., Liu, M.-H., & Shen, Z. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.06.007 · Cited by 52 · see citing works

Aripiprazole, alcohol and substance abuse: a review.

Brunetti, M., Tizio, L. D., Dezi, S., Pozzi, G., Grandinetti, P., & Martinotti, G. (2012) · PubMed · Cited by 48 · see citing works

Impact of aerobic exercise on cognitive impairment and oxidative stress markers in methamphetamine-dependent patients

Zhang, K., Zhang, Q., Jiang, H., Du, J., Zhou, C., Yu, S., Hashimoto, K., & Zhao, M. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.03.032 · Cited by 48 · see citing works

The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice

Snider, S. E., Vunck, S. A., van den Oord, E. J. C. G., Adkins, D. E., McClay, J. L., & Beardsley, P. M. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.01.013 · Cited by 45 · see citing works

Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure

McClay, J. L., Adkins, D. E., Vunck, S. A., Batman, A. M., Vann, R. E., Clark, S. L., Beardsley, P. M., & van den Oord, E. J. C. G. (2012) · Metabolomics · doi:10.1007/s11306-012-0456-y · Cited by 45 · see citing works

Extended‐release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo‐controlled trial

Coffin, P. O., Santos, G., Hern, J., Vittinghoff, E., Santos, D., Matheson, T., Colfax, G. N., & Batki, S. L. (2017) · Addiction · doi:10.1111/add.13950 · Cited by 45 · see citing works

Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta‐analysis of randomised controlled trials

Acheson, L. S., Williams, B. H., Farrell, M., McKetin, R., Ezard, N., & Siefried, K. J. (2022) · Drug and Alcohol Review · doi:10.1111/dar.13511 · Cited by 45 · see citing works

Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine

Zorick, T. S., Sugar, C. A., Hellemann, G., SHOPTAW, S. J., & London, E. D. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.04.015 · Cited by 42 · see citing works

Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment

Kohno, M., Dennis, L. E., McCready, H. D., & Hoffman, W. F. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01180-4 · Cited by 42 · see citing works

Effects of TrkB agonist 7,8-dihydroxyflavone on sensory gating deficits in mice after administration of methamphetamine

Ren, Q., Zhang, J., Fujita, Y., Ma, M., Wu, J., & Hashimoto, K. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.03.016 · Cited by 40 · see citing works

Gender differences in treatment and clinical characteristics among patients receiving extended release naltrexone

Herbeck, D. M., Jeter, K., Cousins, S. J., Abdelmaksoud, R., & Crevecoeur-MacPhail, D. A. (2016) · Journal of Addictive Diseases · doi:10.1080/10550887.2016.1189659 · Cited by 39 · see citing works

Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats

Miller, M. L., Aarde, S. M., Moreno, A. Y., Creehan, K. M., Janda, K. D., & Taffe, M. A. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.06.014 · Cited by 38 · see citing works

Attenuation of reinstatement of methamphetamine-, sucrose-, and food-seeking behavior in rats by fenobam, a metabotropic glutamate receptor 5 negative allosteric modulator

Watterson, L. R., Kufahl, P. R., Nemirovsky, N. E., Sewalia, K., Hood, L. E., & Olive, M. F. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2804-z · Cited by 38 · see citing works

Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence

Simmler, L. D., Wandeler, R., & Liechti, M. E. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-220 · Cited by 38 · see citing works

Methamphetamine-induced toxicity: The role of autophagy?

Roohbakhsh, A., Shirani, K., & Karimi, G. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.10.012 · Cited by 38 · see citing works

Interventions for Non-Injection Substance Use Among US Men Who Have Sex with Men: What is Needed

Santos, G., Das, M., & Colfax, G. N. (2011) · AIDS and Behavior · doi:10.1007/s10461-011-9923-0 · Cited by 37 · see citing works

Effects of methamphetamine self-administration on actigraphy-based sleep parameters in rhesus monkeys

Andersen, M. L., Diaz, M. P., Murnane, K. S., & Howell, L. L. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2943-2 · Cited by 37 · see citing works

A novel dopamine D3 receptor antagonist YQA14 inhibits methamphetamine self-administration and relapse to drug-seeking behaviour in rats

Chen, Y., Song, R., Yang, R., Wu, N., & Li, J. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.09.026 · Cited by 37 · see citing works

A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder

Kohno, M., Dennis, L. E., McCready, H. D., Schwartz, D. L., Hoffman, W. F., & Korthuis, P. T. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.045 · Cited by 36 · see citing works

Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder

Roche, D. J. O., Worley, M. J., Courtney, K. E., Bujarski, S., London, E. D., SHOPTAW, S. J., & Ray, L. A. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4607-8 · Cited by 32 · see citing works

The methamphetamine problem

Galbraith, N. D. (2015) · BJPsych Bulletin · doi:10.1192/pb.bp.115.050930 · Cited by 33 · see citing works

Advances and challenges in pharmacotherapeutics for amphetamine-type stimulants addiction

Cao, D.-N., Shi, J.-J., Hao, W., Wu, N., & Li, J. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.03.040 · Cited by 34 · see citing works

Comparison of the effects of methamphetamine, bupropion, and methylphenidate on the self-administration of methamphetamine by rhesus monkeys.

Schindler, C. W., Gilman, J. P., Panlilio, L. V., McCann, D. J., & Goldberg, S. R. (2011) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0022432 · Cited by 32 · see citing works

Rivastigmine reduces “likely to use methamphetamine” in methamphetamine-dependent volunteers

Garza, R. D. L., Newton, T. F., Haile, C. N., Yoon, J. H., Nerumalla, C. S., Mahoney, J. J., & Aziziyeh, A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.014 · Cited by 32 · see citing works

Interleukin-1 Receptor Antagonist Reduces Neonatal Lipopolysaccharide-Induced Long-Lasting Neurobehavioral Deficits and Dopaminergic Neuronal Injury in Adult Rats

Pang, Y., Tien, L., Zhu, H., Shen, J.-Y., Wright, C., Jones, T., Mamoon, S., Bhatt, A., Cai, Z., & Fan, L. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16048635 · Cited by 32 · see citing works

Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population

Lappin, J., Roxburgh, A., Kaye, S. S., Chalmers, J., Sara, G. E., Dobbins, T., Burns, L., & Farrell, M. (2016) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2016.10.018 · Cited by 30 · see citing works

Effect of prenatal methadone on reinstated behavioral sensitization induced by methamphetamine in adolescent rats

Wong, C., Lee, Y., Chiang, Y., Fan, L., Ho, I.-K., & Tien, L. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.10.027 · Cited by 28 · see citing works

Methanolic extract of Morinda citrifolia Linn. unripe fruit attenuates methamphetamine-induced conditioned place preferences in mice

Pandy, V., Wai, Y. C., Roslan, N. F. A., Sajat, A., Jallb, A. H. A., & Vijeepallam, K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.008 · Cited by 28 · see citing works

Outcomes of compulsory detention compared to community-based voluntary methadone maintenance treatment in Vietnam

Vuong, T. T. A., Ritter, A. J., Shanahan, M., Ali, R., Nguyen, N. T., Pham, K., Vuong, T. T. A., & Giang, L. M. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.01.011 · Cited by 27 · see citing works

Inhibiting effects of rhynchophylline on zebrafish methamphetamine dependence are associated with amelioration of neurotransmitters content and down-regulation of TH and NR2B expression

Jiang, M., Chen, Y., Li, C., Peng, Q., Fang, M., Liu, W., Qun-zhao, K., Lin, Y., Yung, K. K. L., & Mo, Z. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.03.004 · Cited by 27 · see citing works

Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail

Hazani, H. M., Mohamed, I. N., Mustapha, M., Mohamed, W. M. Y., Yahaya, M. F., Teoh, S. L., Mohamed, R. M. P., Isa, M. F. M., Abdulrahman, S. M., Ramadah, R., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.859563 · Cited by 25 · see citing works

Bioenergetics Failure and Oxidative Stress in Brain Stem Mediates Cardiovascular Collapse Associated with Fatal Methamphetamine Intoxication

Li, F. C. H., Yen, J., Chan, S. H. H., & Chang, A. Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030589 · Cited by 26 · see citing works

Chronic modafinil effects on drug-seeking following methamphetamine self-administration in rats

Reichel, C. M., & See, R. E. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000988 · Cited by 26 · see citing works

The Effects of Methylphenidate on Cognitive Control in Active Methamphetamine Dependence Using Functional Magnetic Resonance Imaging

Jan, R. K., Lin, J. C., McLaren, D. G., Kirk, I. J., Kydd, R. R., & Russell, B. R. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00020 · Cited by 26 · see citing works

Melatonin suppresses methamphetamine-triggered endoplasmic reticulum stress in C6 cells glioma cell lines

Tungkum, W., Jumnongprakhon, P., Tocharus, C., Govitrapong, P., & Tocharus, J. (2017) · The Journal of Toxicological Sciences · doi:10.2131/jts.42.63 · Cited by 26 · see citing works

Protective Effect of Melatonin on Methamphetamine-Induced Apoptosis in Glioma Cell Line

Jumnongprakhon, P., Govitrapong, P., Tocharus, C., Tungkum, W., & Tocharus, J. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9419-y · Cited by 25 · see citing works

The effect of N-acetylcysteine or bupropion on methamphetamine self-administration and methamphetamine–triggered reinstatement of female rats

Charntikov, S., Pittenger, S. T., Pudiak, C., & Bevins, R. A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.021 · Cited by 24 · see citing works

Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users

Marks, K. R., Lile, J. A., Stoops, W. W., & Rush, C. R. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3449-x · Cited by 24 · see citing works

Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?

Hersey, M., Bacon, A. K., Bailey, L. G., Coggiano, M. A., Newman, A. H., Leggio, L., & Tanda, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.656475 · Cited by 24 · see citing works

Synthesis and Pharmacological Characterization of a Novel Sigma Receptor Ligand with Improved Metabolic Stability and Antagonistic Effects Against Methamphetamine

Seminerio, M. J., Robson, M. J., Abdelazeem, A. H., Mésangeau, C., Jamalapuram, S., Avery, B. A., McCurdy, C. R., & Matsumoto, R. R. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9311-8 · Cited by 24 · see citing works

Role of Serine Racemase in Behavioral Sensitization in Mice after Repeated Administration of Methamphetamine

Horio, M., Kohno, M., Fujita, Y., Ishima, T., Inoue, R., Mori, H., & Hashimoto, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035494 · Cited by 23 · see citing works

Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial

Schottenfeld, R. S., Chawarski, M. C., Sofuoglu, M., Chooi, W.-T., Zaharim, N. M., Yasin, M. A. M., Ahmad, I., Jaapar, S. Z. S., & Vicknasingam, B. K. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.01.017 · Cited by 22 · see citing works

ELISA Detection of 30 New Amphetamine Designer Drugs in Whole Blood, Urine and Oral Fluid using Neogen®“Amphetamine” and “Methamphetamine/MDMA” Kits

Nieddu, M., Burrai, L., Baralla, E., Pasciu, V., Varoni, M. V., Briguglio, I., Demontis, M. P., & Boatto, G. (2016) · Journal of Analytical Toxicology · doi:10.1093/jat/bkw060 · Cited by 22 · see citing works

Effects of berberine hydrochloride on methamphetamine-induced anxiety behaviors and relapse in rats.

Rezaeian, L., Moghaddam, H. K., Mohseni, F., Khaksari, M., & Rafaiee, R. (2020) · PubMed Central · doi:10.22038/ijbms.2020.47285.10884 · Cited by 22 · see citing works

Dose-dependent changes in the locomotor responses to methamphetamine in BALB/c mice: Low doses induce hypolocomotion

Singh, R. A. K., Kosten, T. A., Kinsey, B. M., Shen, X., Lopez, A. Y., Kosten, T. R., & Orson, F. M. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.08.013 · Cited by 22 · see citing works

The Mglur5 Positive Allosteric Modulator CDPPB Does not Alter Extinction or Contextual Reinstatement of Methamphetamine-Seeking Behavior in Rats

Widholm, J. J., Gass, J. T., & Cleva, R. M. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s1-004 · Cited by 21 · see citing works

Office-Based Addiction Treatment in Primary Care

Edelman, E. J., Oldfield, B. J., & Tetrault, J. M. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.02.007 · Cited by 21 · see citing works

Dépendance à la méthamphétamine : de nombreuses conséquences et complications

Karila, L., Petit, A., Cottencin, O., & Reynaud, M. (2010) · La Presse Médicale · doi:10.1016/j.lpm.2010.09.003 · Cited by 20 · see citing works

Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance

Rush, C. R., Stoops, W. W., Lile, J. A., Glaser, P. E. A., & Hays, L. R. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2067-5 · Cited by 20 · see citing works

Comparison of demographic characteristics and psychiatric comorbidity among methamphetamine-, heroin- and methamphetamine-heroin co- dependent males in Hunan, China

Dong, H., Yang, M., Liu, L., Zhang, C., Liu, M., Shen, Y., Liu, H., & Hao, W. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1346-7 · Cited by 20 · see citing works

Brain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine Overdose

Kitanaka, J., Kitanaka, N., Hall, F., Uhl, G., & Takemura, M. (2016) · Drug Target Insights · doi:10.4137/dti.s38342 · Cited by 13 · see citing works

A Scoping Review on Cue Reactivity in Methamphetamine Use Disorder

Seow, E., Ong, W. J., Hombali, A. S., Asharani, P. V., & Subramaniam, M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186504 · Cited by 19 · see citing works

Efficacy of Repetitive Transcranial Magnetic Stimulation in Patients With Methamphetamine Use Disorder: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials

Chang, C.-H., Liou, M.-F., Liu, C., Lu, W.-H., & Chen, S.-J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.904252 · Cited by 19 · see citing works

Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine

Marks, K. R., Lile, J. A., Stoops, W. W., Glaser, P. E. A., Hays, L. R., & Rush, C. R. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000488 · Cited by 19 · see citing works

Morphine intake and the effects of naltrexone and buprenorphine on the acquisition of methamphetamine intake

Eastwood, E., & Phillips, T. J. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12100 · Cited by 19 · see citing works

The role of thioredoxin-1 in resisting methamphetamine-induced rewarding effect

Huang, M., Kong, L., Yang, L., Li, X., Zhou, X., Li, Y., & Bai, J. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.07.047 · Cited by 18 · see citing works

Neural mechanisms linked to treatment outcomes and recovery in substance-related and addictive disorders

Mestre‐Bach, G., & Potenza, M. N. (2023) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2023.2242359 · Cited by 18 · see citing works

Addiction à la cocaïne et aux psychostimulants

Lacoste, J., Delavenne, H., Charles‐Nicolas, A., Garcia, F. D., & Jehel, L. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.07.013 · Cited by 18 · see citing works

Microglia contribute to methamphetamine reinforcement and reflect persistent transcriptional and morphological adaptations to the drug

Vilca, S. J., Margetts, A. V., Höglund, L., Fleites, I., Bystrom, L. L., Pollock, T. A., Bourgain‐Guglielmetti, F., Wahlestedt, C., & Tuesta, L. M. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.05.038 · Cited by 18 · see citing works

Differential behavioral responses of the spontaneously hypertensive rat to methylphenidate and methamphetamine: lack of a rewarding effect of repeated methylphenidate treatment

Peña, I. D., Lee, J. C., Lee, H. L., Woo, T. S., Lee, H. C., Sohn, A. R., & Cheong, J. H. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.02.090 · Cited by 17 · see citing works

c-Fos immunoreactivity of neural cells in intoxication due to high-dose methamphetamine

Tomita, M., Katsuyama, H., WATANABE, Y., Shibaike, Y., Yoshinari, H., Tee, J. W., Iwachidou, N., & Miyamoto, O. (2013) · The Journal of Toxicological Sciences · doi:10.2131/jts.38.671 · Cited by 16 · see citing works

Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance

Lile, J. A., Stoops, W. W., Glaser, P. E. A., Hays, L. R., & Rush, C. R. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.06.006 · Cited by 16 · see citing works

The effect of VMAT2 inhibitor GZ-793A on the reinstatement of methamphetamine-seeking in rats

Alvers, K. M., Beckmann, J. S., Zheng, G., Crooks, P. A., Dwoskin, L. P., & Bardo, M. T. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2748-3 · Cited by 16 · see citing works

Immunopharmacotherapeutic advancements in addressing methamphetamine abuse

Lee, J. C., & Janda, K. D. (2020) · RSC Chemical Biology · doi:10.1039/d0cb00165a · Cited by 16 · see citing works

Abuse Potential of Oral Phendimetrazine in Cocaine-dependent Individuals

Bolin, B. L., Stoops, W. W., Sites, J. P., & Rush, C. R. (2016) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000206 · Cited by 15 · see citing works

Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice

Kitanaka, N., Kitanaka, J., Hall, F. S., Uhl, G. R., Watabe, K., Kubo, H., Takahashi, H., Tanaka, K.-I., Nishiyama, N., & Takemura, M. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000030 · Cited by 15 · see citing works

Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat

Kufahl, P. R., & Olive, M. F. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s1-003 · Cited by 15 · see citing works

Methamphetamine Dependency

Lashkaripour, K., & Torbati, E. (2012) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba.5336 · Cited by 15 · see citing works

Pharmacotherapy for Methamphetamine Dependence: A Review of the Pathophysiology of Methamphetamine Addiction and the Theoretical Basis and Efficacy of Pharmacotherapeutic Interventions

Rose, M. E., & Grant, J. E. (2008) · Annals of Clinical Psychiatry · doi:10.1080/10401230802177656 · Cited by 121 · see citing works

Pharmacotherapy of Methamphetamine Addiction: An Update

Elkashef, A. M., Vocci, F. J., Hanson, G. R., White, J. M., WICKES, W. A., & Tiihonen, J. (2008) · Substance Abuse · doi:10.1080/08897070802218554 · Cited by 121 · see citing works

Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review

Siefried, K. J., Acheson, L. S., Lintzeris, N., & Ezard, N. (2020) · CNS Drugs · doi:10.1007/s40263-020-00711-x · Cited by 194 · see citing works

Pharmacotherapy of amphetamine-type stimulant dependence: An update

Brensilver, M., Heinzerling, K., & Shoptaw, S. (2013) · Drug and Alcohol Review · doi:10.1111/dar.12048 · Cited by 122 · see citing works

Background

(2016)